Drug Shortage Report for AMPICILLIN SODIUM FOR INJECTION BP
| Report ID | 235334 |
| Drug Identification Number | 02462346 |
| Brand name | AMPICILLIN SODIUM FOR INJECTION BP |
| Common or Proper name | AMPICILLIN SODIUM FOR INJECTION BP |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | AMPICILLIN |
| Strength(s) | 2G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 20Ml Vial X 10 |
| ATC code | J01CA |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-08-15 |
| Estimated end date | Unknown |
| Actual end date | 2025-02-18 |
| Shortage status | Resolved |
| Updated date | 2025-02-19 |
| Company comments | Please be informed that AMPICILLIN SODIUM FOR INJECTION BP is now available under the Eugia label.DIN:02530511 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-02-19 | French | Compare |
| v4 | 2025-02-19 | English | Compare |
| v3 | 2024-08-16 | English | Compare |
| v2 | 2024-08-15 | French | Compare |
| v1 | 2024-08-15 | English | Compare |
Showing 1 to 5 of 5